| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/17425255.2016.1178238 |
| P8608 | Fatcat ID | release_rhovj7qxjngezbm3nyitm4lbrm |
| P698 | PubMed publication ID | 27087416 |
| P50 | author | Steven C Wallis | Q58397119 |
| Jason A. Roberts | Q38544404 | ||
| Jeffrey Lipman | Q53678222 | ||
| Suzanne L Parker | Q57656495 | ||
| Tavey Dorofaeff | Q57732826 | ||
| Daynia E Ballot | Q57874861 | ||
| P2093 | author name string | Rossella M Bandini | |
| P2860 | cites work | On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples | Q33442157 |
| Simultaneous quantitation of metformin and sitagliptin from mouse and human dried blood spots using laser diode thermal desorption tandem mass spectrometry | Q33449881 | ||
| Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS. | Q33770850 | ||
| A good practice guide to the administration of substances and removal of blood, including routes and volumes | Q34141695 | ||
| Pharmacokinetics of ertapenem in healthy young volunteers. | Q34141850 | ||
| Developmental pharmacology--drug disposition, action, and therapy in infants and children | Q34247047 | ||
| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions | Q34274190 | ||
| DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic | Q34329290 | ||
| Suitability of capillary blood glucose analysis in patients receiving vasopressors | Q35074156 | ||
| Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study | Q35278193 | ||
| Fast simultaneous LC/MS/MS determination of 10 active compounds in human serum for therapeutic drug monitoring in psychiatric medication. | Q35669723 | ||
| Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients | Q36072500 | ||
| Population Pharmacokinetics of Fosfomycin in Critically Ill Patients. | Q36075930 | ||
| Validation and Application of a Dried Blood Spot Ceftriaxone Assay | Q36439065 | ||
| Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era. | Q36733177 | ||
| Effect of protein binding of daptomycin on MIC and antibacterial activity | Q36757414 | ||
| Microsample analyses via DBS: challenges and opportunities. | Q38153799 | ||
| Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies | Q38180558 | ||
| Methods for pharmacokinetic analysis in young children | Q38187157 | ||
| Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis | Q38283321 | ||
| Dried blood spots for monitoring and individualization of antiepileptic drug treatment. | Q38431932 | ||
| The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I). | Q38708590 | ||
| Personalized monitoring of therapeutic salicylic acid in dried blood spots using a three-layer setup and desorption electrospray ionization mass spectrometry. | Q38985344 | ||
| Evaluation of two blood microsampling approaches for drug discovery PK studies in rats | Q39134249 | ||
| Validation of a ligand binding assay using dried blood spot sampling | Q39523488 | ||
| Use of a novel technique, solid phase microextraction, to measure tranexamic acid in patients undergoing cardiac surgery | Q39691208 | ||
| Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial | Q40156961 | ||
| Differences between pharmacokinetics and toxicokinetics | Q40418721 | ||
| Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling | Q40427519 | ||
| Dried blood spot analysis without dilution: Application to the LC-MS/MS determination of BMS-986001 in rat dried blood spot. | Q40572896 | ||
| Novel membrane devices and their potential utility in blood sample collection prior to analysis of dried plasma spots | Q40587840 | ||
| Simultaneous determination of tedizolid and linezolid in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study | Q40831130 | ||
| A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery. | Q40998498 | ||
| Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood | Q41052029 | ||
| Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients. | Q41441506 | ||
| Applying dried blood spot sampling with LCMS quantification in the clinical development phase of tasquinimod | Q41584077 | ||
| Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry | Q42066076 | ||
| Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots | Q42247766 | ||
| Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. | Q42249983 | ||
| Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium | Q42607519 | ||
| Use of dried blood spots in drug development: pharmacokinetic considerations | Q42739574 | ||
| The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. | Q42806942 | ||
| Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot | Q43993986 | ||
| Anemia and blood transfusion in critically ill patients. | Q44266321 | ||
| Validation of a bioanalytical method using capillary microsampling of 8 µl plasma samples: application to a toxicokinetic study in mice | Q44514074 | ||
| Evaluation of dried blood spots for the quantification of therapeutic monoclonal antibodies and detection of anti-drug antibodies | Q44686846 | ||
| Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. | Q44725242 | ||
| Bioanalytical implementation of plasma capillary microsampling: small hurdles, large gains | Q44854538 | ||
| Impact of plasma protein binding on antimicrobial activity using time-killing curves | Q45096419 | ||
| Utilization of DBS Within Drug Discovery: Development of a Serial Microsampling Pharmacokinetic Study in Mice | Q45998866 | ||
| Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. | Q46112178 | ||
| Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol | Q46498070 | ||
| A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots. | Q46503725 | ||
| Newborn screening blood spot analysis in the UK: influence of spot size, punch location and haematocrit | Q47378592 | ||
| Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling | Q47798292 | ||
| The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood | Q47909387 | ||
| Determination of antibiotic drug concentrations in circulating human blood by means of solid phase micro-extraction | Q48568291 | ||
| DBS and beyond | Q49116051 | ||
| Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study | Q49134614 | ||
| A novel approach to capillary plasma microsampling for quantitative bioanalysis. | Q50491603 | ||
| Will 'green' aspects of dried blood spot sampling accelerate its implementation and acceptance in the pharmaceutical industry? | Q50494818 | ||
| Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS. | Q50568163 | ||
| Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles. | Q51275877 | ||
| Bioanalysis of emixustat (ACU-4429) in whole blood collected with volumetric absorptive microsampling by LC-MS/MS. | Q51788747 | ||
| Pharmacokinetics of drugs in blood. VII: Unusual distribution and blood storage effect of vancomycin. | Q52421471 | ||
| Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. | Q53150109 | ||
| A validated method for the quantification of fosfomycin on dried plasma spots by HPLC-MS/MS: application to a pilot pharmacokinetic study in humans. | Q53180705 | ||
| A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. | Q53359634 | ||
| Determination of tamoxifen and endoxifen in dried blood spots using LC-MS/MS and the effect of coated DBS cards on recovery and matrix effects. | Q53664909 | ||
| Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis. | Q53802726 | ||
| A validated LC–MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot | Q57728123 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| P304 | page(s) | 601-614 | |
| P577 | publication date | 2016-04-18 | |
| P1433 | published in | Expert Opinion on Drug Metabolism & Toxicology | Q5421205 |
| P1476 | title | Is there a role for microsampling in antibiotic pharmacokinetic studies? | |
| P478 | volume | 12 |
Search more.